Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) EBITDA Margin (2024 - 2025)

Incannex Healthcare's EBITDA Margin history spans 2 years, with the latest figure at 135840.0% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 8327333.0% year-over-year to 135840.0%; the TTM value through Dec 2025 reached 483030.0%, down 45472884.0%, while the annual FY2025 figure was 54302.33%, 9986434.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 135840.0% at Incannex Healthcare, down from 124000.0% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 6866.22% in Q3 2024 and bottomed at 135840.0% in Q4 2025.